首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer
【24h】

Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer

机译:15(S)-羟基二十碳四烯酸和13-S-羟基十八碳二烯酸在非小细胞肺癌中的抗肿瘤作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUNDPrevious studies have shown that the levels of 15-lipoxygenase 1 (15-LOX-1) and 15-LOX-2 as well as their metabolites 13-S-hydroxyoctadecadienoic acid (13(S)-HODE) and 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) are significantly reduced in smokers with non-small cell lung carcinoma (NSCLC). Furthermore, animal model experiments have indicated that the reduction of these molecules occurs before the establishment of cigarette smoking carcinogen-induced lung tumors, and this suggests roles in lung tumorigenesis. However, the functions of these molecules remain unknown in NSCLC.
机译:背景以前的研究表明15-脂氧合酶1(15-LOX-1)和15-LOX-2的水平及其代谢产物13-S-羟基十八碳二烯酸(13(S)-HODE)和15(S)-非小细胞肺癌(NSCLC)吸烟者的羟基二十碳四烯酸(15(S)-HETE)显着降低。此外,动物模型实验表明,这些分子的减少发生在吸烟致癌物诱发的肺肿瘤建立之前,这表明在肺肿瘤发生中的作用。但是,这些分子的功能在NSCLC中仍然未知。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号